331 related articles for article (PubMed ID: 20442299)
1. Differentiation therapy exerts antitumor effects on stem-like glioma cells.
Campos B; Wan F; Farhadi M; Ernst A; Zeppernick F; Tagscherer KE; Ahmadi R; Lohr J; Dictus C; Gdynia G; Combs SE; Goidts V; Helmke BM; Eckstein V; Roth W; Beckhove P; Lichter P; Unterberg A; Radlwimmer B; Herold-Mende C
Clin Cancer Res; 2010 May; 16(10):2715-28. PubMed ID: 20442299
[TBL] [Abstract][Full Text] [Related]
2. Eckol suppresses maintenance of stemness and malignancies in glioma stem-like cells.
Hyun KH; Yoon CH; Kim RK; Lim EJ; An S; Park MJ; Hyun JW; Suh Y; Kim MJ; Lee SJ
Toxicol Appl Pharmacol; 2011 Jul; 254(1):32-40. PubMed ID: 21514314
[TBL] [Abstract][Full Text] [Related]
3. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
[TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans-retinoic acid on C6 glioma cell proliferation and differentiation].
Tang K; Cao L; Fan SQ; Wu MH; Huang H; Zhou YH; Zhou M; Tang YL; Wang R; Zeng F; Liao P; Li XL; Li GY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):892-7. PubMed ID: 19001730
[TBL] [Abstract][Full Text] [Related]
5. Responsiveness of stem-like human glioma cells to all-trans retinoic acid and requirement of retinoic acid receptor isotypes α, β and γ.
Choschzick I; Hirseland E; Cramer H; Schultz S; Leppert J; Tronnier V; Zechel C
Neuroscience; 2014 Oct; 279():44-64. PubMed ID: 25171789
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal differentiation of glioblastoma stem cells.
Ricci-Vitiani L; Pallini R; Larocca LM; Lombardi DG; Signore M; Pierconti F; Petrucci G; Montano N; Maira G; De Maria R
Cell Death Differ; 2008 Sep; 15(9):1491-8. PubMed ID: 18497759
[TBL] [Abstract][Full Text] [Related]
7. Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells.
Williams RF; Sims TL; Tracey L; Myers AL; Ng CY; Poppleton H; Nathwani AC; Davidoff AM
Anticancer Res; 2010 Sep; 30(9):3301-8. PubMed ID: 20944101
[TBL] [Abstract][Full Text] [Related]
8. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
[TBL] [Abstract][Full Text] [Related]
9. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.
Fukaya R; Ohta S; Yamaguchi M; Fujii H; Kawakami Y; Kawase T; Toda M
Cancer Lett; 2010 May; 291(2):150-7. PubMed ID: 19913993
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study of combination therapy against human glioma xenograft by differentiation-inducing agent and cytotoxic chemotherapeutic drug].
Shi MG; Huang Q; Dong J; Sun ZF; Lan Q
Ai Zheng; 2002 Oct; 21(10):1090-4. PubMed ID: 12508650
[TBL] [Abstract][Full Text] [Related]
11. All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells.
Li RJ; Ying X; Zhang Y; Ju RJ; Wang XX; Yao HJ; Men Y; Tian W; Yu Y; Zhang L; Huang RJ; Lu WL
J Control Release; 2011 Feb; 149(3):281-91. PubMed ID: 20971141
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma.
Al-Tahan A; Sarkis O; Harajly M; Baghdadi OK; Zibara K; Boulos F; Dighe D; Kregel S; Bazarbachi A; El-Sabban M; Skapek SX; Saab R
Pediatr Blood Cancer; 2012 Jun; 58(6):877-84. PubMed ID: 21755593
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
Damjanov I; Horvat B; Gibas Z
Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
[TBL] [Abstract][Full Text] [Related]
14. [Differentiation treatment by all-trans retinoic acid reduces phenotype of glioma stem cells].
Zhang SJ; Wan F; Hu F; Xie RF; Wang Y; Wang BF; Ye F; Guo DS; Lei T
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):19-22. PubMed ID: 23578447
[TBL] [Abstract][Full Text] [Related]
15. Tumor initiating potential of side population cells in human gastric cancer.
Fukuda K; Saikawa Y; Ohashi M; Kumagai K; Kitajima M; Okano H; Matsuzaki Y; Kitagawa Y
Int J Oncol; 2009 May; 34(5):1201-7. PubMed ID: 19360333
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid for the treatment of pediatric malignant glioma.
Driever PH; Knüpfer MM; Cinatl J; Wolff JE
Klin Padiatr; 1999; 211(4):323-8. PubMed ID: 10472571
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner.
Karsy M; Albert L; Tobias ME; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2010 Dec; 30(12):4915-20. PubMed ID: 21187470
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
[TBL] [Abstract][Full Text] [Related]
19. Autocrine factors sustain glioblastoma stem cell self-renewal.
Li G; Chen Z; Hu YD; Wei H; Li D; Ji H; Wang DL
Oncol Rep; 2009 Feb; 21(2):419-24. PubMed ID: 19148517
[TBL] [Abstract][Full Text] [Related]
20. Brain tumor stem cells: bringing order to the chaos of brain cancer.
Dirks PB
J Clin Oncol; 2008 Jun; 26(17):2916-24. PubMed ID: 18539973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
